Lipid-Based Nanocarriers for Ophthalmic Administration: Towards Experimental Design Implementation
Nanotherapeutics based on biocompatible lipid matrices allow for enhanced solubility of poorly soluble compounds in the treatment of ophthalmic diseases, overcoming the anatomical and physiological barriers present in the eye, which, despite the ease of access, remains strongly protected. Micro-/nan...
Main Authors: | Felipe M. González-Fernández, Annalisa Bianchera, Paolo Gasco, Sara Nicoli, Silvia Pescina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/4/447 |
Similar Items
-
The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and
Nanostructured Lipid Carriers; A Comparative Literature Review
by: Leila Azhar Shekoufeh Bahari, et al.
Published: (2016-06-01) -
Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies
by: Cláudia Pina Costa, et al.
Published: (2021-04-01) -
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa
by: Chiara Bianca Maria Platania, et al.
Published: (2019-01-01) -
Lipid Nanostructured Particles as Emerging Carriers for Targeted Delivery of Bioactive Molecules: Applications in Food and Biomedical Sciences (An Overview)
by: Patricia MUNTEAN, et al.
Published: (2020-05-01) -
Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
by: Behzad Sharif Makhmal Zadeh, et al.
Published: (2018-04-01)